Premium
No evidence of a correlation between BCL10 expression and API2‐MALT1 gene rearrangement in ocular adnexal MALT lymphoma
Author(s) -
Adachi Akiko,
Tamaru Junichi,
Kaneko Kou,
Kuroda Hajime,
Miura Ichiro,
Kojima Takayoshi,
Hoshino Shigeru,
Ichinohasama Ryo,
Itoyama Shinji
Publication year - 2004
Publication title -
pathology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 74
eISSN - 1440-1827
pISSN - 1320-5463
DOI - 10.1111/j.1440-1827.2004.01580.x
Subject(s) - bcl10 , malt lymphoma , lymphoma , pathology , lymphoid hyperplasia , t cell lymphoma , medicine , biology
In the present study, 62 cases of ocular adnexal lymphoproliferative disorders were reviewed clinicopathologically. Of them, 51 were extranodal marginal zone B‐cell lymphoma (MALT lymphoma), five were diffuse large B‐cell lymphoma (DLBCL), one was peripheral T‐cell lymphoma, one was NK/T cell lymphoma, nasal type, and four were reactive lymphoid hyperplasia. These lymphoma cases showed a favorable clinical course and localized disease, except for the case of NK/T cell lymphoma, although 19 cases (32.8%) had a recurrence of disease. To clarify the correlation between BCL10 protein expression and API2–MALT1 gene rearrangement, the 51 cases of MALT lymphoma and 5 cases of DLBCL were analyzed by immunohistochemical and RT‐PCR methods. Nuclear BCL10 expression was identified in 58% of MALT lymphoma cases, but not in any DLBCL cases. There was no evidence of a correlation between aberrant nuclear BCL10 expression and the clinical parameters examined in the present study. API2–MALT1 transcription was not demonstrated in either the MALT lymphoma cases or the DLBCL cases studied using a multiplex one‐tube reverse transcriptase‐PCR method. These findings indicate that the nuclear expression of BCL10 is unlikely to correlate with the API2‐MALT1 fusion gene in ocular adnexal MALT lymphoma.